Cargando…

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder

PURPOSE: Medication nonadherence is common in the treatment of patients with severe mental illness and is a frequent cause of relapse. Different formulations have been developed in an effort to improve medication adherence. The aim of this study was to explore whether there are differential clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novick, Diego, Montgomery, William, Treuer, Tamas, Koyanagi, Ai, Aguado, Jaume, Kraemer, Susanne, Haro, Josep Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476712/ https://www.ncbi.nlm.nih.gov/pubmed/28652711 http://dx.doi.org/10.2147/PPA.S124581

Ejemplares similares

Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study
por: Novick, Diego, et al.
Publicado: (2015)

An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report
por: Hobbs, David, et al.
Publicado: (2013)

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study
por: Bitter, Istvan, et al.
Publicado: (2010)

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
por: Xue, Hai Bo Haber, et al.
Publicado: (2014)

Sex differences in the course of schizophrenia across diverse regions of the world
por: Novick, Diego, et al.
Publicado: (2016)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties
por: Zhao, Jingping, et al.
Publicado: (2014)

Empirically driven definitions of “good,” “moderate,” and “poor” levels of functioning in the treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2012)

Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023)

Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
por: Ye, Wenyu, et al.
Publicado: (2014)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
por: Ascher-Svanum, Haya, et al.
Publicado: (2014)

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
por: Novick, Diego, et al.
Publicado: (2016)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
por: Hong, Jihyung, et al.
Publicado: (2012)

Orodispersible tablets: A new trend in drug delivery
por: Dey, Paramita, et al.
Publicado: (2010)

Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets
por: Vlad, Robert-Alexandru, et al.
Publicado: (2021)

Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia
por: Hong, Jihyung, et al.
Publicado: (2014)

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
por: Hong, Jihyung, et al.
Publicado: (2013)

Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
por: Montgomery, William, et al.
Publicado: (2012)

Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients
por: Czekalla, Jörg, et al.
Publicado: (2007)

Taste Masked Microspheres of Ofloxacin: Formulation and Evaluation of Orodispersible Tablets
por: Malik, Karan, et al.
Publicado: (2011)

A survey of patient preferences for a placebo orodispersible tablet
por: Wade, Alan G, et al.
Publicado: (2012)

Preparation and Evaluation of Orodispersible Tablets of Pheniramine Maleate by Effervescent Method
por: Swamy, P. V., et al.
Publicado: (2009)

Development of Orodispersible Tablets of Candesartan Cilexetil-β-cyclodextrin Complex
por: Sravya, Maddukuri, et al.
Publicado: (2013)

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
por: Montgomery, William, et al.
Publicado: (2014)

Lallemantia reylenne seeds as superdisintegrant: Formulation and evaluation of nimesulide orodispersible tablets
por: Malik, Karan, et al.
Publicado: (2011)

Fast disintegrating crystalline solid dispersions of simvastatin for incorporation into orodispersible tablets
por: Pabari, Ritesh M, et al.
Publicado: (2014)

Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits
por: Aljimaee, Yazeed HM, et al.
Publicado: (2015)

Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method
por: Kalyankar, P., et al.
Publicado: (2015)

Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects
por: Teng, Renli, et al.
Publicado: (2017)

Fused Deposition Modeling as a Possible Approach for the Preparation of Orodispersible Tablets
por: Tranová, Thao, et al.
Publicado: (2022)

The Influence of the Intergranular Superdisintegrant Performance on New Drotaverine Orodispersible Tablet Formulations
por: Vlad, Robert-Alexandru, et al.
Publicado: (2023)

Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?
por: Hong, Jihyung, et al.
Publicado: (2015)

Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
por: Montgomery, William, et al.
Publicado: (2015)

The potential role of appetite in predicting weight changes during treatment with olanzapine
por: Case, Michael, et al.
Publicado: (2010)

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence
por: Miehlke, Stephan, et al.
Publicado: (2020)

Bioequivalence and Bioavailability of an Orodispersible Tablet of Sildenafil Citrate in Healthy Chinese Male Subjects
por: Lv, Yuan, et al.
Publicado: (2020)

Contribution to determining the antioxidant capacity of melatonin in orodispersible tablets – comparison with reference antioxidants
por: Muñoz, Herminia, et al.
Publicado: (2020)

Sugar content and erosive potential of commonly prescribed Orodispersible tablets- An in vitro study.
por: Anand, Lahari, et al.
Publicado: (2023)

Development of Orodispersible Tizanidine HCl Tablets Using Spray Dried Coprocessed Exipient Bases
por: Masareddy, Rajashree, et al.
Publicado: (2011)

Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets
por: Pabari, RM, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vp017l7q9jfhnjci6mkeu5pm4k